PCI Pharma Services begins installation of sterile fill-finish and lyophilization line as part of $100m expansion

Construction and validation activities at leading CDMO’s Bedford, NH campus will conclude later this year, with GMP production commencing early 2025.

LATEST AI & VR IN HEALTHCARE NEWS